These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20173718)

  • 41. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.
    Kim NH; Park RH; Park JB
    Plast Reconstr Surg; 2010 Jun; 125(6):1693-1705. PubMed ID: 20517093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unilateral masseter muscle hypertrophy: morphofunctional analysis of the relapse after treatment with botulinum toxin.
    Peretta R; Melison M; Meneghello R; Comelli D; Guarda L; Galzignato PF; Concheri G; Ferronato G
    Cranio; 2009 Jul; 27(3):200-10. PubMed ID: 19697649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
    Xue Z; Zeng W; Chen Z; Han Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Hwang K
    Dermatol Surg; 2014 Dec; 40(12):1340-1. PubMed ID: 25380090
    [No Abstract]   [Full Text] [Related]  

  • 45. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
    J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of botulinum toxin (botox) in the management of masseter muscle hypertrophy: a simplified technique.
    Andrade NN; Deshpande GS
    Plast Reconstr Surg; 2011 Jul; 128(1):24e-26e. PubMed ID: 21701301
    [No Abstract]   [Full Text] [Related]  

  • 48. [Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients].
    Martí N; Ramón D; Gámez L; Reig I; García-Pérez MA; Alonso V; Jordá E
    Actas Dermosifiliogr; 2010 Sep; 101(7):614-21. PubMed ID: 20858387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
    Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.
    Mandel L; Tharakan M
    J Oral Maxillofac Surg; 1999 Aug; 57(8):1017-9. PubMed ID: 10437733
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
    Tsai CY; Chiu WC; Liao YH; Tsai CM
    Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin treatment of bilateral masseteric hypertrophy.
    Smyth AG
    Br J Oral Maxillofac Surg; 1994 Feb; 32(1):29-33. PubMed ID: 8136335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
    Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
    J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle.
    Kim KS; Byun YS; Kim YJ; Kim ST
    Dermatol Surg; 2009 Dec; 35(12):1902-6. PubMed ID: 19737290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
    Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
    J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.